November 6, 2014

Mylan announced the launch of norethindrone acetate and ethinyl estradiol tablets USP, 1 mg/0.02 mg and ferrous fumarate, which is the generic equivalent to Loestrin 24 Fe from Warner Chilcott. 

November 5, 2014

Mineral Fusion announced the launch of a new, limited-edition holiday kit filled with Lip Tints. 

November 5, 2014

A new study by a Florida State University researcher found that a new dietary supplement is superior to calcium and vitamin D when it comes to bone health.

November 4, 2014

Rogaine brand on Tuesday announced the launch of Women's Rogaine 5% Minoxidil topical aerosol, the first and only once-daily treatment approved by the Food and Drug Administration for the treatment of female pattern hair loss, according to the brand. 

November 3, 2014

Coenzyme Q10 — a compound commonly sold as a dietary supplement — provides health benefits to persons suffering from Gulf War illness symptoms.

October 31, 2014

Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim. 

October 31, 2014

The signs for the retail clinic industry remain positive and conservative but steady growth in the number of clinics is expected to continue as drug stores play an essential role in the segment, according to new research from healthcare market researcher Kalorama Information.

October 30, 2014
Comfoor announced the introduction of Pluggerz, which are earplugs containing anti-allergic silicon material. 
October 30, 2014

Dr. Reddy's Labs on Tuesday announced the launch of sirolimus tablets in 1-mg and 2-mg dosage strengths.

October 23, 2014

Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid.

October 22, 2014

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

October 17, 2014

Pillar Rock USA recently introduced JetRyte, a nutritional supplement formulated to combat jet lag. 

October 17, 2014

Purdue Pharma has launched an awareness campaign to address specific knowledge gaps among pharmacists related to its Schedule III extended-release transdermal opioid, Butrans.

October 16, 2014

 Kaz on Wednesday launched the new Febreze Air Purifier. 

October 15, 2014

The big story in the digestives space is the switch and launch in May of Pfizer’s Nexium 24HR. In a little more than 10 weeks on the shelf, the brand has generated $53.6 million in sales across total U.S. multi-outlets for the 52 weeks ended Aug. 10, according to IRI. 

October 13, 2014

Church & Dwight on Monday announced the launch of Replens Silky Smooth.

October 10, 2014

The Drug Enforcement Administration’s final rule moving hydrocodone combination products from Schedule III to the more-restrictive Schedule II officially went into effect on Monday. 

October 9, 2014

Purdue Pharma on Thursday announced the launch of a new dosage strength of 7.5 mcg/hour for its Butrans (buprenorphine) transdermal system CIII, bringing the total number of strengths offered by the company to five.

October 9, 2014

Expanding on its voluntary ingredient disclosure program, SC Johnson will begin disclosing air care fragrance ingredients present at the highest concentrations down to .09% of the product formula. 

October 8, 2014

Teva Pharmaceutical Industries on Wednesday announced the initiation of a rolling new drug application submission for hydrocodone bitartrate extended-release tablets.

October 7, 2014

Actavis and Durata Therapeutics on Monday announced that they have entered into a definitive merger agreement.

October 6, 2014

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

October 2, 2014

Seroyal on Wednesday announced the Canadian release of Genestra Brands Statin Care, a balanced nutritional supplement formulated to provide nutritional support for patients taking statin medications.

September 30, 2014

Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths.